Skip to main content
. Author manuscript; available in PMC: 2008 Sep 30.
Published in final edited form as: Virology. 2007 Jun 1;366(2):340–348. doi: 10.1016/j.virol.2007.05.001

Figure 5.

Figure 5

Reversibility of ouabain treatment. Cells were treated with 100 nM ouabain and infected with wild type HSV-1 at an MOI of 10. At the indicated times post-infection, the drug containing medium was removed and infection was allowed to proceed in drug-free media. Viral yield was determined by titration at 24 hours post infection.